Growth Metrics

Omeros (OMER) Total Current Liabilities (2010 - 2026)

Omeros recorded quarterly Total Current Liabilities of $59.4 million in Q1 2026, down 23.85% quarter-over-quarter from $78.1 million in Q4 2025, and down 28.57% year-over-year from $83.2 million in Q1 2025.

Omeros' Total Current Liabilities history runs 17 years deep, the most recent figure standing at $59.4 million for Q1 2026.

  • In Q1 2026, Total Current Liabilities fell 28.57% year-over-year to $59.4 million; the TTM figure through Mar 2026 stood at $59.4 million (down 28.57% YoY), while the FY2025 annual figure was $78.1 million, down 1.84% from the prior year.
  • Total Current Liabilities came in at $59.4 million for Q1 2026 at Omeros, down from $78.1 million in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $147.2 million in Q3 2023 to a low of $35.1 million in Q1 2022.
  • A 5-year average of $80.8 million and a median of $78.1 million in 2025 frame the typical range for Total Current Liabilities.
  • Across the five-year window, Total Current Liabilities surged 296.94% in 2023 and sank 62.21% in 2024, its largest moves.
  • Omeros' Total Current Liabilities stood at $136.4 million in 2022, then slumped by 60.91% to $53.3 million in 2023, then jumped by 49.16% to $79.5 million in 2024, then decreased by 1.84% to $78.1 million in 2025, then fell by 23.85% to $59.4 million in 2026.
  • According to Business Quant data, Total Current Liabilities over the past three periods registered $59.4 million, $78.1 million, and $80.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 16.35 Mn
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - 1.70 Mn
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 636.40 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - 66.94 Mn
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 13.42 Mn
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 3.88 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 5.11 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 1.35 Bn
10 Omeros 772.03 Mn 636.71 Mn 9.31 Mn 59.44 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 59.44 Mn
Dec 31, 2025 78.06 Mn
Sep 30, 2025 80.76 Mn
Jun 30, 2025 85.50 Mn
Mar 31, 2025 83.22 Mn
Dec 31, 2024 79.53 Mn
Sep 30, 2024 55.62 Mn
Jun 30, 2024 59.48 Mn
Mar 31, 2024 59.06 Mn
Dec 31, 2023 53.32 Mn
Sep 30, 2023 147.18 Mn
Jun 30, 2023 143.54 Mn
Mar 31, 2023 139.19 Mn
Dec 31, 2022 136.38 Mn
Sep 30, 2022 39.51 Mn
Jun 30, 2022 38.50 Mn
Mar 31, 2022 35.07 Mn
Dec 31, 2021 51.79 Mn
Sep 30, 2021 42.82 Mn
Jun 30, 2021 47.70 Mn
Mar 31, 2021 43.43 Mn
Dec 31, 2020 36.74 Mn
Sep 30, 2020 47.72 Mn
Jun 30, 2020 38.05 Mn
Mar 31, 2020 57.94 Mn
Dec 31, 2019 55.46 Mn
Sep 30, 2019 46.75 Mn
Jun 30, 2019 40.67 Mn
Mar 31, 2019 44.51 Mn
Dec 31, 2018 37.36 Mn
Sep 30, 2018 24.59 Mn
Jun 30, 2018 24.44 Mn
Mar 31, 2018 24.63 Mn
Dec 31, 2017 26.31 Mn
Sep 30, 2017 24.69 Mn
Jun 30, 2017 24.75 Mn
Mar 31, 2017 16.97 Mn
Dec 31, 2016 16.07 Mn
Sep 30, 2016 16.06 Mn
Jun 30, 2016 16.07 Mn
Mar 31, 2016 17.52 Mn
Dec 31, 2015 16.25 Mn
Sep 30, 2015 22.27 Mn
Jun 30, 2015 20.10 Mn
Mar 31, 2015 20.07 Mn
Dec 31, 2014 18.32 Mn
Sep 30, 2014 14.40 Mn
Jun 30, 2014 12.17 Mn
Mar 31, 2014 10.23 Mn
Dec 31, 2013 11.87 Mn
Sep 30, 2013 11.90 Mn
Jun 30, 2013 10.90 Mn
Mar 31, 2013 10.59 Mn
Dec 31, 2012 8.36 Mn
Sep 30, 2012 21.81 Mn
Jun 30, 2012 17.25 Mn
Mar 31, 2012 18.74 Mn
Dec 31, 2011 18.99 Mn
Sep 30, 2011 15.82 Mn
Jun 30, 2011 14.34 Mn
Dec 31, 2010 15.37 Mn